Deep learning detects precancerous changes on mammograms

A mammography-based deep learning model was recently shown to detect precancerous changes on imaging in a racially diverse population of women, prompting experts to suggest that it could have utility in facilitating earlier diagnosis of breast cancer.

What’s more, the model proved beneficial in a large cohort that included women with benign breast disease and BRCA mutations. Experts detailed their work with the model (Marai) in a new paper published in Radiology: Artificial Intelligence on July 26.

Researchers included more than 6,000 screening mammograms acquired over a 14-year period from 2,096 patients in their analysis. Using area under the receiver operating characteristic curve (AUC) as a metric of performance, the team tested the model’s utility to detect subtle changes in the patients’ imaging. BI-RADS assessment categories also were used as comparison.

The model achieved one- and five-year AUCs of 0.71 and 0.65 for predicting breast cancer. It performed slightly better on exams of women without dense breasts compared to those with increased density, yielding AUCs of 0.72 versus 0.58. Compared to BI-RADS assessments, the model offered similar one-year predictions, but outperformed BI-RADS categories for longer term predictions (five-year).

Experts were able to best measure the model’s performance using images of the future-affected breast, suggesting that it was identifying early premalignant changes and could have utility in detecting cancers in their earliest developmental stages.

Corresponding author of the paper Dezheng Huo, with the Biological Sciences Division at the University of Chicago, and colleagues suggested that their results “support further examination of mammography deep learning for breast cancer risk prediction in high-risk, racially diverse groups.”

The study abstract is available here.

Hannah murhphy headshot

In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She began covering the medical imaging industry for Innovate Healthcare in 2021.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.